(Q40610026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

review article

1 reference

title

Immune promotion of central nervous system remyelination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

M Rodriguez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D J Miller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

Progress in Brain Research

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

343-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

Mature oligodendrocytes. Division following experimental demyelination in adult animals

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Pre-oligodendrocytes from adult human CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

The longstanding MS lesion. A quantitative MRI and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Glycolipids and transmembrane signaling in oligodendroglia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Amplification of the immune response by agonistic antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Intravenous gamma globulin in progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Disorganization of myelinogenesis in tissue culture by anti-CNS antiserum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Thyroglobulin release-stimulating activity in immunoglobulin G from patients with Graves' disease studied by human thyroid cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Remyelination in Multiple Sclerosis With Peripheral Type Myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Remyelination in the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

PDGF and intracellular signaling in the timing of oligodendrocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Treatment of Guillain-Barré syndrome with high-dose gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Demyelination and Remyelination in Murine Viral Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Stimulation of myelin lipid synthesis in vitro by white matter antiserum in absence of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Demyelinative myelopathy in mice induced by the DA virus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

B cells and antibodies in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Proliferation of mature oligodendrocytes after trauma to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Evolving concepts and issues in remyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Can oligodendrocytes attached to myelin proliferate?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Evidence for a “dying‐back” gliopathy in demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

FGF modulates the PDGF-driven pathway of oligodendrocyte development.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

A role for fibroblast growth factor in oligodendrocyte development.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

The potential for oligodendrocyte proliferation during demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Multiple sclerosis: remyelination of nascent lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Oligodendrocyte proliferation and enhanced CNS remyelination after therapeutic manipulation of chronic relapsing EAE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Virus-induced demyelination in mice: "dying back" of oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Multiple sclerosis: basic concepts and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Immunoglobulins promote remyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Ultrastructure of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Remyelination by oligodendrocytes stimulated by antiserum to spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

First results of immunotherapy with immunoglobulin G in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Phorbol ester enhances morphological differentiation of oligodendrocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2961148-6

7 January 2021

10.1016/S0079-6123(08)61148-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7886217%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference